For stromal keratitis and uveitis, topical corticosteroids are used judiciously with close monitoring
peaks during dose escalation, typically mild-moderate Diarrhea -- 10-20%, usually transient Constipation -- 8-15% Vomiting -- 5-15%, more frequent at higher doses Injection site reactions -- 5-10%, mild erythema and pruritus Decreased appetite -- 5-12%, related to mechanism of action Pancreatitis -- rare but monitored (as with all GLP-1/amylin agents) Gallbladder events -- cholelithiasis reported, consistent with rapid weight loss Trial data describes dose titration as central to tolerability -- the 16-week escalation protocol substantially reduced GI adverse events
General epi-fluorescence and confocal microscopy imaging Images were acquired on Nikon Ti 2E (Nikon Corporation, Chiyoda, Tokyo, Japan) inverted epi-fluorescent microscope equipped with a 60X oil objective and Photometrics 95B camera
However during one of my races I fell over a barrier and have had hip problems for about two months since
Most patients self-inject at home with a 30 gauge insulin syringe
[DOI] [PubMed] [Google Scholar] 1002
